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Abstract: Cardiovascular disease is one of the leading
causes of death in the United States, and new treatments
need to be developed in order to provide novel therapies.
Tissue engineering aims to develop biologic substitutes that
restore tissue function. The purpose of the current study
was to construct cell-based pumps, which can be viewed as
biologic left ventricular assist devices.The pumps were fab-
ricated by culturing cardiac, skeletal, and smooth muscle
cells within a fibrin gel and then each 3-D tissue construct
was wrapped around a decellularized rodent aorta. We
described the methodology for pump fabrication along
with functional performance metric, determined by the
intra-luminal pressure. In addition, histologic evaluation
showed a concentric organization of components, with the
muscle cells positioned on the outermost surface, followed
by the fibrin gel and the decellularized aorta formed the
innermost layer. Though early in development, cell-based
muscle pumps have tremendous potential to be used for
basic and applied research, and with further development,
can be used clinically as cell-based left ventricular assist
devices. Key Words: Tissue engineering—Regenera-
tive medicine—Heart—Cell culture—Pressure—Decellu-
lar scaffold—Tissue construct—3-D.
Heart failure can be a result of many physiologic
abnormalities, including myocyte death and dysfunc-
tion, ventricular remodeling postmyocardial infarc-
tion or any of these combinations (1). Current
therapies to treat heart failure are limited to surgical
transplantation, pharmaceutical intervention, and
mechanic cardiac support (2). Even though these
treatments have improved the quality of patient care,
there are numerous limitations to these approaches.
For example, mechanic circulatory support devices
such as left ventricular assist devices (LVADs) are
used as a bridge to cardiac transplantation; however,
these devices suffer due to thrombogenicity, rejec-
tion, and infection (3). The ability to engineer a cell-
based cardiac pump may provide an alternative to
mechanic LVADs. A cell-based cardiac pump would
be composed of a hollow chamber surrounded by
contracting cardiac cells with one-way valves for uni-
directional flow (4). The cell-based alternatives to
mechanic LVADS would offer a higher degree of
immune tolerance and would reduce the need for
long-term anticoagulant and immunosuppression
therapy. The goal of this study is to fabricate func-
tional 3-D pumps from smooth, skeletal, and cardiac
muscle cells, and to evaluate each pump’s contractile
capabilities in response to chemical and mechanic
stimulation.
MATERIALS AND METHODS
Approval for animal use was granted by the Uni-
versity Committee for the Use and Care of Animals
in accordance with the “Guide for the Care and Use
of Laboratory Animals” (NIH publication 86-23,
1996). Aortas were excised from adult Sprague–
Dawley rats and were completely decellularized
using a detergent-based process, according to a pub-
lished protocol (5). Primary cardiac myocytes were
isolated from 2- to 3-day old Sprague–Dawley rat
hearts using an established protocol (6). Skeletal
muscle cells were isolated from rat soleus muscle
using a previously published protocol (7). Vascular
smooth muscle cells were purchased from Cambrex
(Walkersville, MD, USA; catalog no. CC-2571, lot no.
4F1292) and cultured based on a previously pub-
lished protocol (8). In order to fabricate 3-D pumps,
tissue culture plates were prepared on the surface of
a fibrin gel (Fig. 1A,B). Cardiac cells were plated at
1 ¥ 106 cells/plate and skeletal/smooth muscle cells
were plated at 0.5 ¥ 106 cells/plate. The muscle cells
were maintained under sterile cell culture conditions
for a period of 4–5 days with media changes every
other day. After the cell monolayer had compacted
the fibrin gel to approximately 50% of the original
volume, the decellularized aortas were placed at the
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center of the plates (Fig. 1C). The muscle cells con-
tinued to compact the fibrin gel toward the center of
the culture surface (Fig. 1D). At the center of the
plate, the cell monolayer was physically wrapped
around the decellularized aortas using sterile forceps
(Fig. 1E). The constructs were maintained for an
additional 7 days to promote pump formation (Fig.
1F). Miniature pressure transducers were used to
FIG. 1. Methodology for pump formation. (A) Tissue culture surfaces were coated with polydimethylsiloxane and anchor points (size 0
braided silk sutures), pinned to the center of plate using 0.1-mm diameter mintuetin pins. (B) Primary cells (cardiac, skeletal, or smooth)
were suspended in a fibrin gel and plated on the surface of the tissue culture plate. (C) Once gel compaction started (typically 3–4 days
after initial cell plating), a decellularized aorta was pinned to the center of the plate. (D) Gel compaction continued, with the decellularized
aorta positioned at the center of culture surface. (E) Attachment of the cell monolayer to the decellularized aorta resulted in the formation
of a cell-based pump. (F) Photograph of a cell-based cardiac pump formed utilizing primary cardiac myocytes. (G–J) Decellularization of
rat aortas—detergent-based process to remove cellular components was used. (G) Freshly isolated aorta. (H) Decellularized aorta. (I)
Hematoxylin and eosin (H&E) stain of freshly isolated aorta—cell nucleus identified by circle. (J) H&E stain of de-cellularized aortas—no
cells can be seen.
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measure intra-luminal pressure. For cardiac pumps,
intra-luminal pressure was recorded in response
to spontaneous contractions, in the absence of any
electric or chemical stimulation. For skeletal muscle
pumps, intra-luminal pressure was recorded in
response to electric stimulation, using an impulse of
pulse width of 1.2 ms, voltage of 20 V, and frequencies
of 1 and 60 Hz. For smooth muscle pumps, the intra-
luminal pressure was recorded in response to chemi-
cal stimulation using 10 mM of norepinephrine (NE).
All pressure measurements were conducted at a
single time point of 14 days after initial cell plating.
Following mechanical testing, the cell-based pumps




We used a detergent-based decellularization pro-
tocol developed by our group. Using this protocol, we
were able to completely remove cellular and nucleic
material, while keeping the extracellular matrix
intact. Macroscopic changes in the rodent aorta were
observable as a loss of cellularity, which led to
changes in tissue appearance (Fig. 1G,H). The effi-
ciency of the decellularization protocol was assessed
using H&E stain, and the absence of nucleic material
was observed (Fig. 1I,J); an intact extracellular
matrix can also be seen. This decellularization proce-
dure was reproducibly repeated for 25+ rodent
aortas.
3-D culture of cardiac, skeletal, and smooth
muscle cells
Previously described methods were used to culture
primary cardiac, skeletal, and smooth muscle cells
within a 3-D fibrin gel. Culture of primary cardiac
cells within a fibrin gel resulted in a spontaneously
contracting tissue construct, with macroscopic con-
tractions observable under an inverted microscope at
low magnification (10¥). Culture of primary skeletal
muscle cells within a fibrin gel resulted in cell prolif-
eration, seen using an inverted microscope, which
demonstrated an increase in the surface area popu-
lated by skeletal myocytes. Changing the culture
environment by reducing the media serum concen-
tration promoted the formation of contracting myo-
tubes; this led to fibrin gel compaction. Culture of
primary smooth muscle cells (derived from an aortic
source) resulted in cell proliferation and gel compac-
tion; there were no macroscopic signs of spontaneous
contractions and/or cell fusion. For each of the three
cell types (cardiac, skeletal, and smooth), we fabri-
cated 10+ plates by culturing within a 3-D fibrin gel
and the behavior of the cells was consistent.
3-D pump formation
In order to fabricate 3-D pumps, 8 mm segments of
decellularized rat aortas were placed in the center of
the compacting fibrin gel, with cardiac, skeletal,
and/or smooth muscle cells (as described in Materials
and Methods). Gel compaction resulted in radial
movement of the fibrin gel toward the vessel
segment. The fibrin gel was then physically wrapped
around the decellularized vessel and subsequent
culture resulted in 3-D pump formation. Over time, in
culture, the cell monolayer became more compact
and more closely associated with the aorta (evident
under an inverted microscope). Spontaneous con-
tractions (frequency of 1–2 Hz) of the 3-D pumps
were observed only for the constructs fabricated
using cardiac cells; these contractions were visible
under an inverted microscope. A total of 30+ pumps
were fabricated using this procedure with an 80%
success rate, with success being defined as the forma-
tion of 3-D construct. In 10% of the pumps, there was
contamination which likely resulted from the physi-
cal wrapping of the fibrin gel around decellularized
vascular segments. In another 10% of the cases, the
fibrin gel did not adhere to the vascular segments;
rather, the 3-D fibrin gel with the muscle cells
remained in culture as an independent entity.
Functional evaluation of 3-D pumps—intra-luminal
pressure
The intra-luminal pressure of 3-D cardiac pumps
was measured during spontaneous contractions and
was on average 0.12 mm Hg with the average fre-
quency of 1.5 Hz (Fig. 2A). The smooth muscle
pumps were only excitable upon chemical stimula-
tion and in response to 10 mM NE, an average pres-
sure of 0.008 mm Hg was obtained (Fig. 2B). For the
skeletal pump, there were no spontaneous contrac-
tions and intra-luminal pressure was only recorded
upon electric stimulation (Fig. 2C,D). When the 3-D
skeletal pumps were electrically stimulated at a fre-
quency of 1 Hz, the number of pressure waves corre-
lated with the pacing frequency; individual twitch
contractions were observed (Fig. 2C). However,
when the pacing frequency was increased to 60 Hz,
tetanus contractions were observed, with a magni-
tude of 0.025 mm Hg (Fig. 2D).
Histologic evaluation of 3-D pumps
Histologic evaluation of the pumps showed the
presence of an intact acellular vessel, with concentric
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FIG. 2. Functional performance of cell-based pumps. (A) Cardiac pump—in the absence of electric stimulation, the cardiac pumps were
capable of generating spontaneous contractions. The average pressure was on the order of 0.014 mm Hg and the frequency of
spontaneous contractions was approximately 1.5 Hz. (B) Smooth muscle pump—the smooth muscle pumps were stimulated with 10 mM
of norepinephrine (NE) and the intra-luminal pressure recorded for a period of 140 s. The point at which the NE was added is indicated
by an arrow. The average pressure was recorded to be 0.008 mm Hg. (C–D) Skeletal muscle pump—the skeletal muscle pumps were
subjected to electric stimulation, using a pulse width of 1.2 ms, voltage of 20 V, and two different frequencies: (C) 1 Hz and (D) 60 Hz.
The average pressure was 0.025 mm Hg at 60 Hz. (E) Histologic evaluation of muscle-based pump—a segment of decellularized aortic
tissue was used as the scaffold material, with primary muscle cells culture in a fibrin gel, wrapped around the peripheral surface. (F)
Tri-layer structure of 3-D pump—a high magnification image of the muscle-based pump showing the organization of the decellular aorta,
fibrin gel, and muscle cells. Images are for skeletal muscle pump and are representative of pumps fabricated with all three muscle types
(cardiac, skeletal, and smooth).
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alignment of a fibrin gel followed by muscle cells on
the outer surface of the 3-D pump (Fig. 2E). The
acellular vessel was completely intact and retained its
3-D architecture, and it was evident that no cellular
material was present within the vascular segment
(Fig. 2F). The cell component of the pump was sepa-
rated from the vascular segment by the fibrin gel; this
prevented physical contact between the cells and the
vascular segment (Fig. 2F). However, cells were
evident around the entire circumferential surface of
the 3-D pumps. This arrangement of the vascular
segment, fibrin gel, and muscle cells was independent
of the cell type being used and was a function of the
methodology implemented for the formation of 3-D
pumps.
DISCUSSION AND CONCLUSIONS
In this study, we describe a novel method to
bioengineer 3-D cell-based pumps using cardiac, skel-
etal, and smooth muscle cells. We describe the meth-
odology for pump formation and demonstrate
functional performance based on intra-luminal
pressure. In this section, we discuss the following five
topics: (i) the need for cell-based pumps; (ii) meth-
odology for pump formation; (iii) functional perfor-
mance of cell-based pumps; (iv) technological
advancements required to develop these pumps
further; and (v) path to clinical applications.
Need for cell-based pumps
In this study, we describe methodology to fabricate
functional 3-D cell-based pumps. The concept of cell-
based pumps has not been extensively explored in
the research literature and very few scientific publi-
cations can be found discussing this topic. Therefore,
prior to presenting our discussion for this study, it
would be useful to describe what exactly cell-based
pumps are and how can they be used in a research
and/or clinical setting. Cell-based pumps can be
viewed as biologic devices capable of generating
pressure upon spontaneous or electrically/chemically
induced contractions. Although these devices are
early in development, they can be conceptually
viewed as biologic alternatives to LVADs. LVADs are
used as a bridge to heart transplantation and function
by pumping blood directly from the apex of the heart
to the aorta, completely bypassing the failing left
ventricle. However, LVADs are devices and suffer
from thrombogenicity problems, something cell-
based alternatives would reduce.
Methodology for 3-D pump formation
In order to fabricate 3-D pumps, primary muscle
cells were cultured within a 3-D fibrin gel and then
physically wrapped around a decellularized aortic
vascular segment. This resulted in the fibrin gel being
placed in close proximity to the decellular scaffold,
leading to attachment of the fibrin gel to the scaffold
and the formation of 3-D cell-based pumps. This
method is simple, easy to implement and reproduc-
ible, and most importantly, leads to the formation of
functional pumps. However, one limitation is the dis-
tance between the muscle cells and acellular matrix,
with fibrin gel occupying a substantial volume in
between these two layers. This distance between the
muscle cells and acellular scaffolds dampens the con-
tractile activity of the cells, thereby reducing scaffold
displacement; this reduces pump functionality, mea-
sured by intra-luminal pressure. This is the most
likely explanation of low pressures obtained in this
study. While adequate for a proof of concept study,
subsequent work will need to focus on functional
integration between the muscle cells and the scaffold.
This can be accomplished by promoting fibrin degra-
dation or replacing the 3-D culture system from a
fibrin-based model to one based on self organization
strategies.
Functional performance of cell-based pumps
The functional performance of the 3-D pumps, fab-
ricated using any of the three muscle cell types, was
considerably lower than that of mammalian tissue.
This could partly be due to the concentric organiza-
tion of the acellular scaffold, fibrin gel, and muscle
cells, with the fibrin gel presenting a barrier between
the cells and the scaffold. Another possible explana-
tion for the low functional performance of the pumps
is the single layer of cells which was used in this study.
An increase in intra-luminal pressure of the 3-D
pumps will require multi-layering of the muscle cells
coupled with functional integration of the cells with
the scaffold, without physical hindrance of the inter-
vening fibrin gel. While these strategies would be
required for further development of the pump
model, the current study does provide the foundation
and serves as a proof of concept study.
Technological advancements required to develop
these pumps further
In order to develop the pump model further, the
functional performance of these devices will need to
be closer to that of mammalian tissue. This can be
accomplished by increasing the thickness of the
muscle layer and promoting functional integration
between the cells and the scaffold. While the exact
number of cell layers required remains unknown,
multiple layers will be required; vascularization may
also be needed to support the metabolic activity of
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the increase in cell number. In addition, physiologic
conditioning using mechanical stretch, pulsatile fluid
flow, and chemical conditioning with growth factors
will be required. It will also be important to control
the electric activity of the muscle cells and externally
control stimulation variables (frequency, introduc-
tion of rest periods for skeletal muscle) during long-
term in vitro culture; bioreactors with embedded
stimulators will be required.
Path to clinical applications
The muscle-based pumps are at a nascent stage of
development, and considerable research needs to
be invested prior to using these devices clinically.
Perhaps the most important step in moving the
pump model forward will be the use of stem cells in
place of the primary cells used in this study. Several
stem cell sources are currently under investigation
and human embryonic stem cells, mesenchymal
stem cells, and induced pluripotent cells are all
potential sources for tissue engineering. From an
applications standpoint, cardiac pumps can be used
as actuators in robotic devices, where continuous
performance is necessary. Skeletal and smooth
muscle pumps will be suitable as miniature drug
delivery devices, with skeletal pumps being suitable
for infrequent delivery of high drug doses and
smooth pumps being better for frequent delivery of
low doses of specific molecule.
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